OraSure Technologies (OSUR) Given Average Rating of “Hold” by Brokerages

OraSure Technologies (NASDAQ:OSUR) has earned a consensus recommendation of “Hold” from the seven brokerages that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $20.00.

OSUR has been the subject of a number of research analyst reports. Zacks Investment Research cut shares of OraSure Technologies from a “hold” rating to a “sell” rating in a report on Wednesday, April 18th. BidaskClub raised shares of OraSure Technologies from a “buy” rating to a “strong-buy” rating in a report on Thursday, March 15th. ValuEngine raised shares of OraSure Technologies from a “hold” rating to a “buy” rating in a report on Friday, March 2nd. Finally, TheStreet cut shares of OraSure Technologies from a “b” rating to a “c+” rating in a report on Wednesday, May 2nd.

Several institutional investors have recently modified their holdings of the stock. Dynamic Technology Lab Private Ltd purchased a new position in shares of OraSure Technologies during the first quarter worth $205,000. Principal Financial Group Inc. raised its holdings in shares of OraSure Technologies by 3.3% during the first quarter. Principal Financial Group Inc. now owns 491,188 shares of the medical instruments supplier’s stock worth $8,296,000 after purchasing an additional 15,717 shares during the last quarter. WINTON GROUP Ltd purchased a new position in shares of OraSure Technologies during the first quarter worth $727,000. Legal & General Group Plc raised its holdings in shares of OraSure Technologies by 3.0% during the first quarter. Legal & General Group Plc now owns 113,160 shares of the medical instruments supplier’s stock worth $1,907,000 after purchasing an additional 3,291 shares during the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new position in shares of OraSure Technologies during the first quarter worth $139,000. 92.71% of the stock is owned by hedge funds and other institutional investors.

Shares of NASDAQ OSUR traded up $0.37 during midday trading on Thursday, reaching $17.87. The company had a trading volume of 204,651 shares, compared to its average volume of 606,255. The stock has a market cap of $1.07 billion, a P/E ratio of 35.04, a P/E/G ratio of 4.36 and a beta of 1.68. OraSure Technologies has a 1 year low of $12.86 and a 1 year high of $23.01.

OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings results on Wednesday, May 2nd. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.03. The business had revenue of $41.99 million during the quarter, compared to analysts’ expectations of $40.53 million. OraSure Technologies had a net margin of 9.28% and a return on equity of 6.58%. The business’s quarterly revenue was up 29.0% on a year-over-year basis. During the same quarter last year, the company posted $0.21 earnings per share. sell-side analysts forecast that OraSure Technologies will post 0.32 earnings per share for the current year.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

HunterCoin Tops One Day Trading Volume of $5,149.00
HunterCoin Tops One Day Trading Volume of $5,149.00
Superior Coin  Price Reaches $0.0010 on Top Exchanges
Superior Coin Price Reaches $0.0010 on Top Exchanges
Analysts Anticipate Genesis Energy, L.P.  common stock  Will Post Quarterly Sales of $768.86 Million
Analysts Anticipate Genesis Energy, L.P. common stock Will Post Quarterly Sales of $768.86 Million
OraSure Technologies  Given Average Rating of “Hold” by Brokerages
OraSure Technologies Given Average Rating of “Hold” by Brokerages
Clarus  Expected to Announce Earnings of -$0.01 Per Share
Clarus Expected to Announce Earnings of -$0.01 Per Share
GlycoMimetics   Shares Down 6.1%
GlycoMimetics Shares Down 6.1%


Leave a Reply

© 2006-2018 Ticker Report. Google+.